Stay updated on HPN217 in R/R MM: Safety, PK, Clinical Trial
Sign up to get notified when there's something new on the HPN217 in R/R MM: Safety, PK, Clinical Trial page.

Latest updates to the HPN217 in R/R MM: Safety, PK, Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference2%
- Check22 days agoChange DetectedTerminology changed from Plasma cell myeloma to Multiple myeloma and the page version updated to v3.1.0.SummaryDifference0.1%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1; the Back to Top element has been removed, indicating a minor UI cleanup alongside the version update.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check51 days agoChange DetectedThe web page has undergone significant changes, including the removal of specific location details and the deletion of references to Multiple Myeloma, while adding new information about Plasma cell myeloma and Hemic and Lymphatic Diseases.SummaryDifference1%
- Check65 days agoChange DetectedThe webpage has updated its clinical trial data identifiers and timelines, extending the duration from up to 4 years to up to 6 years, and has replaced some URLs for accessing trial data.SummaryDifference3%
Stay in the know with updates to HPN217 in R/R MM: Safety, PK, Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HPN217 in R/R MM: Safety, PK, Clinical Trial page.